443,563 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by Geode Capital Management LLC

Geode Capital Management LLC acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 443,563 shares of the company's stock, valued at approximately $7,920,000. Geode Capital Management LLC owned approximately 1.32% of Grail as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Crcm LP purchased a new position in Grail in the fourth quarter worth $65,061,000. Primecap Management Co. CA purchased a new position in shares of Grail in the 4th quarter worth about $37,118,000. Vanguard Group Inc. purchased a new position in shares of Grail in the 4th quarter worth about $25,902,000. Bank of New York Mellon Corp bought a new position in Grail during the fourth quarter valued at about $6,262,000. Finally, TCW Group Inc. purchased a new stake in Grail during the fourth quarter worth about $5,095,000.

Wall Street Analysts Forecast Growth

GRAL has been the subject of several research reports. Canaccord Genuity Group initiated coverage on Grail in a report on Monday, April 21st. They set a "buy" rating and a $32.00 price objective for the company. Morgan Stanley boosted their price objective on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th.

Grail Stock Performance

GRAL traded down $1.13 during trading on Tuesday, reaching $35.77. 1,092,821 shares of the company were exchanged, compared to its average volume of 1,223,072. The company's 50-day moving average is $30.83 and its two-hundred day moving average is $24.58. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. Research analysts forecast that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Insider Activity at Grail

In other news, President Joshua J. Ofman sold 2,109 shares of the company's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the sale, the president now owns 559,673 shares of the company's stock, valued at approximately $17,461,797.60. This represents a 0.38 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the completion of the transaction, the chief executive officer now owns 828,662 shares in the company, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 11,550 shares of company stock valued at $360,436 over the last three months.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.